Potential Probiotic Lactobacillus rhamnosus (MTCC-5897) Inhibits Escherichia coli Impaired Intestinal Barrier Function by Modulating the Host Tight Junction Gene Response
- 60 Downloads
Probiotic as a preventive medicine is emerging as an indispensable tool in addressing the foodborne infections or gastrointestinal disorders. The present study was sought to determine the in vitro prophylactic potential of probiotic Lactobacillus rhamnosus (LR: MTCC-5897) against Escherichia coli (ATCC 14948) induced impairment in intestinal barrier function using Caco-2 cells. Intestinal cells exposed to E. coli demonstrated significantly higher phenol red flux (p < 0.05) and concomitantly decreased TEER (0.69 ± 0.01) in contrast to control or L. rhamnosus (109 cfu/mL)-treated cells. However, E. coli-induced barrier hyperpermeability was restored to significant extents (p < 0.01) when E. coli were excluded, competed or displaced by probiotic LR. Similarly, exposure of Caco-2 cells to E. coli reduced the mRNA expression of key tight junction genes, viz. Zo-1, Claudin-1, Occludin and Cingulin which however were restored significantly (p < 0.05) with L. rhamnosus treatment during exclusion or competition than displacement assays. The protective behaviour of probiotic LR against E. coli can also be observed in immunofluorescent and electron micrograph where intact cellular morphology along with preserved distribution and localisation of key integrity proteins can be found in LR-treated cells in contrast to distorted and disorganised distribution observed with E. coli exposure. In conclusion, L. rhamnosus inhibited and re-established E. coli-impaired intestinal barrier function by improving the expression and distribution of key junction protein and hence could serve an essential food additive to address the various health complications especially those associated with gastrointestinal tract.
KeywordsIntestinal permeability Lactobacillus rhamnosus Tight junctions Transepithelial electrical resistance Phenol red flux
We are highly indebted to the Department of BioTechnology, Ministry of Science and Technology, New Delhi for providing necessary funds (BT/PR15109/PFN/20/1174/2015) required for the present work. The funding agency has no role in the design, analysis or writing of this article. The authors also acknowledge ICAR National Dairy Research Institute (NDRI) Karnal, for providing the laboratory facilities for execution of this work.
Compliance with ethical standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Laskowska E, Jarosz LS, Grądzki Z (2018) Effect of the EM Bokashi® multimicrobial probiotic preparation on the non-specific immune response in pigs. Probiotics Antimicrob Proteins:1–14. https://doi.org/10.1007/s12602-018-9460-5
- 4.Zielinska D, Dlugosz E, Zawistowska-Deniziak A (2018) Functional properties of food origin Lactobacillus in the gastrointestinal ecosystem in vitro Study. Probiotics Antimicrob Proteins 23:1–10Google Scholar
- 6.Garcia MA, Nelson WJ, Chavez N (2018) Cell–cell junctions organize structural and signaling networks. Cold Spring Harb Perspect 10:029181Google Scholar
- 10.Secher T, Kassem S, Benamar M, Bernard I, Boury M, Barreau F, Oswald E, Saoudi A (2017) Oral administration of the probiotic strain Escherichia coli Nissle 1917 reduces susceptibility to neuroinflammation and repairs experimental autoimmune encephalomyelitis-induced intestinal barrier dysfunction. Front Immunol 8:1096PubMedPubMedCentralCrossRefGoogle Scholar
- 11.Ekmekciu I, von Klitzing E, Fiebiger U, Neumann C, Bacher P, Scheffold A, Bereswill S, Heimesaat MM (2017) The probiotic compound VSL# 3 modulates mucosal, peripheral and systemic immunity following murine broad-spectrum antibiotic treatment. Front Cell Infect Microbiol 7:167PubMedPubMedCentralCrossRefGoogle Scholar
- 13.Saliganti V, Kapila R, Kapila S (2016) Consumption of probiotic Lactobacillus rhamnosus (MTCC: 5897) containing fermented milk plays a key role in development of the immune system in newborn mice during the suckling–weaning transition. Microbiol Immunol 60:261–267PubMedCrossRefPubMedCentralGoogle Scholar
- 16.Bhat MI, Kumari A, Kapila S, Kapila R (2019) Probiotic lactobacilli mediated changes in global epigenetic signatures of human intestinal epithelial cells during Escherichia coli challenge. Ann Microbiol 2019:1–10Google Scholar
- 25.West CE, Renz H, Jenmalm MC, Kozyrskyj AL, Allen KJ, Vuillermin P, Prescott SL, MacKay C, Salminen S, Wong G, Sinn J (2015) The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immunol 135:3–13PubMedCrossRefPubMedCentralGoogle Scholar
- 27.Bambou JC, Giraud A, Menard S, Begue B, Rakotobe S, Heyman M, Taddei F, Cerf-Bensussan N, Gaboriau-Routhiau V (2004) In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J Biol Chem 279:42984–42992PubMedCrossRefPubMedCentralGoogle Scholar
- 31.Ismail M (1999) The use of Caco-2 cells as an in vitro method to study bioavailability of iron. Malays J Nutr 5:31–45Google Scholar
- 34.Ziegler AL, Pridgen TA, Mills JK, Gonzalez LM, Van Landeghem L, Odle J, Blikslager AT (2018) Epithelial restitution defect in neonatal jejunum is rescued by juvenile mucosal homogenate in a pig model of intestinal ischemic injury and repair. PLoS One 13:e0200674PubMedPubMedCentralCrossRefGoogle Scholar
- 37.Samtiya M, Bhat MI, Gupta T, Kapila S, Kapila R (2019) Safety assessment of potential probiotic Lactobacillus fermentum MTCC-5898 in murine model after repetitive dose for 28 days (Sub-Acute Exposure). Probiotics Antimicrob Proteins 8:1–2Google Scholar
- 39.Alvarez CS, Badia J, Bosch M, Gimenez R, Baldoma L (2016) Outer membrane vesicles and soluble factors released by probiotic Escherichia coli Nissle 1917 and commensal ECOR63 enhance barrier function by regulating expression of tight junction proteins in intestinal epithelial cells. Front Microbiol 7:1981PubMedPubMedCentralGoogle Scholar
- 47.Roselli M, Finamore A, Hynonen U, Palva A, Mengheri E (2016) Differential protection by cell wall components of Lactobacillus amylovorus DSM 16698 T against alterations of membrane barrier and NF-kB activation induced by enterotoxigenic F4+ Escherichia coli on intestinal cells. BMC Microbiol 16:226PubMedPubMedCentralCrossRefGoogle Scholar